UAB "Pharmasanta group" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 111,026 |
| 23,522 |
| 368,844 |
| -368,844 |
| -78,145 |
| 22.38 |
| -332.21 |
| -1,447,111 |
| 12,820,340 |
| 11,022,262 |
| 350,531 |
| 2023 |
|---|
| 75,150 |
| 19,025 |
| 1,440,679 |
| 1,440,679 |
| 364,729 |
| 14.23 |
| 1,917.07 |
| -6,432 |
| 11,264,332 |
| 10,918,240 |
| 339,603 |
| 2024 |
|---|
| 57,600 |
| 25,374 |
| 1,754,546 |
| 1,754,546 |
| 772,928 |
| 30.60 |
| 3,046.09 |
| 1,748,115 |
| 11,709,581 |
| 13,396,779 |
| 60,428 |
Register and
explore Okredo data| 2024 |
|---|
| 57,600 |
| 25,374 |
| 1,754,546 |
| 1,754,546 |
| 772,928 |
| 30.60 |
| 3,046.09 |
| 1,748,115 |
| 11,709,581 |
| 13,396,779 |
| 60,428 |
Register and
explore Okredo data2024
Turnover (€)
57,600 €
-23 % *
Sales per employee (€)
25,374 €
33 % *
Profit before tax (€)
1,754,546 €22 % *
Net Profit (€)
1,754,546 €22 % *
Profit per employee (€)
772,928 €112 % *
Total profitability (%)
30.60 %115.04 % *
Net profitability (%)
3,046.09 %58.89 % *
Equity (€)
1,748,115 €27,278 % *
Amounts Payable And Liabilities (€)
11,709,581 €
4 % *
Non-current Assets (€)
13,396,779 €23 % *
CurrentAssets (€)
60,428 €
-82 % *